HDAC9 and Cognitive impairment: Two novel HDAC inhibitors, mercaptoacetamide-based class II HDACI (represented by W2) and hydroxyamide-based class I and II HDACI (represented by I2), were developed recently and both could reduce Aβ levels obviously and restored cognitive impairment.